Clinical Trial Update: Treatment for Elderly Patients With High Risk Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update from Amgen regarding treatment for elderly patients with high-risk breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Amgen | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED